Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3

Clinical trial NCT00685412 · COMPLETED

Trial details

NCT number: NCT00685412
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2008-05-01
Primary completion: 2011-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.